Summit Therapeutics Inc. — All Filings
526 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
20-F
25-NSE
3
4
4/A
424B3
424B4
424B5
5
6-K
6-K/A
8-A12B
8-K
8-K/A
8-K12B
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
F-1
F-1/A
F-3
F-3/A
F-6
PRE 14A
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001599298-25-000044 | Feb 24, 2025 | — |
| 10-K | 10-K | 0001599298-25-000048 | Feb 24, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001599298-25-000038 | Jan 24, 2025 | Jan 22, 2025 |
| UPLOAD | — | 0000000000-25-000593 | Jan 21, 2025 | — |
| 4 | FORM 4 | 0001599298-25-000036 | Jan 14, 2025 | Jan 12, 2025 |
| 8-K | 8-K | 0001599298-25-000034 | Jan 13, 2025 | — |
| 4 | FORM 4 | 0001599298-25-000025 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000026 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000027 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000028 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000029 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000023 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000030 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | FORM 4 | 0001599298-25-000022 | Jan 6, 2025 | Jan 2, 2025 |
| CORRESP | — | 0001599298-25-000018 | Jan 6, 2025 | — |
| UPLOAD | — | 0000000000-24-014045 | Dec 19, 2024 | — |
| 8-K | 8-K | 0001599298-24-000156 | Oct 30, 2024 | — |
| 10-Q | 10-Q | 0001599298-24-000158 | Oct 30, 2024 | Sep 30, 2024 |
| 4 | FORM 4 | 0001599298-24-000150 | Oct 15, 2024 | Oct 11, 2024 |
| 4 | FORM 4 | 0001599298-24-000146 | Oct 3, 2024 | — |
| D | — | 0001599298-24-000142 | Sep 26, 2024 | — |
| S-3ASR | S-3ASR | 0001193125-24-222200 | Sep 19, 2024 | — |
| 4 | FORM 4 | 0001599298-24-000141 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | FORM 4 | 0001599298-24-000135 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | FORM 4 | 0001599298-24-000136 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | FORM 4 | 0001599298-24-000138 | Sep 13, 2024 | Sep 11, 2024 |
| SC 13D/A | SC 13D/A | 0001193125-24-218980 | Sep 13, 2024 | — |
| 4 | FORM 4 | 0001599298-24-000139 | Sep 13, 2024 | Sep 11, 2024 |
| 8-K | 8-K | 0001193125-24-217618 | Sep 12, 2024 | Sep 11, 2024 |
| 8-K | 8-K | 0001599298-24-000128 | Sep 9, 2024 | Sep 8, 2024 |
| 4 | FORM 4 | 0001599298-24-000123 | Aug 23, 2024 | — |
| 4 | FORM 4 | 0001599298-24-000125 | Aug 23, 2024 | — |
| S-3ASR | S-3ASR | 0001193125-24-194475 | Aug 6, 2024 | — |
| 8-K | 8-K | 0001599298-24-000113 | Aug 6, 2024 | — |
| 10-Q | 10-Q | 0001599298-24-000117 | Aug 6, 2024 | Jun 30, 2024 |
| 4 | FORM 4 | 0001599298-24-000107 | Jun 27, 2024 | — |
| 8-K | 8-K | 0001599298-24-000103 | Jun 27, 2024 | — |
| 3 | FORM 3 | 0001599298-24-000105 | Jun 27, 2024 | — |
| D | — | 0000950123-24-006261 | Jun 18, 2024 | — |
| 8-K | 8-K | 0001193125-24-162715 | Jun 17, 2024 | Jun 12, 2024 |
| DEFA14A | DEFA14A | 0001599298-24-000098 | Jun 13, 2024 | — |
| 8-K | 8-K | 0001193125-24-152292 | Jun 3, 2024 | May 31, 2024 |
| 8-K | 8-K | 0001193125-24-152309 | Jun 3, 2024 | — |
| 8-K | 8-K | 0001599298-24-000096 | May 30, 2024 | — |
| 8-K | 8-K | 0001599298-24-000092 | May 24, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-136721 | May 13, 2024 | — |
| 8-K | 8-K | 0001599298-24-000089 | May 13, 2024 | — |
| 10-Q | 10-Q | 0001599298-24-000085 | May 1, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001599298-24-000087 | May 1, 2024 | — |
| S-8 | INITIAL REGISTRATION STATEMENT | 0001999371-24-005506 | May 1, 2024 | — |